Company: SCLXW
Filing Date: 2025-10-28
Form Type: PRE 14A
Source: 0001193125-25-253884
Chunk: 32

Company: Scilex Holding Co
Filing Date: 2025-10-28
Form: PRE 14A
Chunk 32
---
     |        |     * |   |     |                          |          — |     |           |      — |     |       |     * |   |
| Yue Alexander Wu, Ph.D.(7)                                      |     |              |    19,817 |    |     |        |     * |   |     |                          |          — |     |           |      — |     |       |     * |   |
| All Directors and Executive Officers as a Group (5 individuals) |     |              |   324,293 |    |     |        |  4.11 | % |     |                          |          — |     |           |      — |     |       |  3.68 | % |
| 5% Beneficial Owners                                            |     |              |           |    |     |        |       |   |     |                          |            |     |           |        |     |       |       |   |
| SCLX Stock Acquisition JV LLC                                   |     |              | 1,472,281 | -8 |     |        | 19.37 | % |     |                          | 29,057,097 |     |           | 100.00 |     |       | 28.10 | % |
| Oramed Pharmaceuticals Inc.                                     |     |              |   764,277 | -9 |     |        |  9.15 | % |     |                          |          — |     |           |      — |     |       |  8.24 | % |

| * | Less than 1%. |

| (1) | Unless otherwise indicated, the business address of each of the following individuals is 960 San Antonio Road, 
 Palo Alto, CA 94303.                                                                                           |

| (2) | Mr. Shah resigned from his position as our Chief Executive Officer and President, effective as of                      
 August 17, 2025 and from his role as a director, effective as of September 22, 2025. Accordingly, information relating |

23

| to Mr. Shah is as of September 22, 2025. Represents 314,812 shares subject to options exercisable within 60 days of October 17, 2025, 3,980 shares held directly and an 
 aggregate of 4,453 shares held by family trusts for the benefit of Mr. Shah, his spouse and his children.                                                               |

| (3) | Represents 248,